Business Standard

Thursday, December 26, 2024 | 01:09 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Best of BS Opinion: Covid-19 vaccine, promise of techno-nationalism & more

Here's a selection of Business Standard opinion pieces for the day

economic recovery, revival, economy, growth, gdp, market
Premium

Illustration: Binay Sinha

Kanika Datta New Delhi
A day after the Indian drug regulator’s announcement that it has approved Covid-19 vaccines manufactured by the Serum Institute and Bharat Biotech, serious questions have been raised regarding the transparency and credibility of the approval process. The top edit sets out some of the anomalies experts have raised suggesting that greater transparency is vital to forestall widespread mistrust in the vaccine, defeating the very purpose of this fast-tracked approval for a rapid return to normalcy. Read it here
 
Other views examine the assumptions in Budget-making this year, India’s rising techno-nationalism and the implications of economic coalitions with China.
 
As state

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in